Глава 2

We use cookies. Read the Privacy and Cookie Policy

Глава 2

1. Weinberg, Robert A., 1996. How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.

2. Pollack, M.N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566.

Pollack, M.N., Huynh, H.T., and Lefebvre, S.P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br Cancer Res Treat, 22, 91-100.

Pollack, M.N., Polychronakos, C., Yousefi, S., and Richard, M., 1988. Characterisation of insulin-like growth factor-1 (IGF-1) receptors of human breast cancer cells. Biochem Biophy Res Commun, 154, 1, 326–331.

3. Oliff, Alien, Gibbs, Jackson, B. and McCormick, Frank, 1996. New Molecular Targets for Cancer Therapy. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 144–149.

4. Weinberg, Robert A., 1996, How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62–70.

5. Jain, R. K., 1994. Barriers to Drug Delivery in Solid Tumours. Scientific American, July, 271 (1), pp. 58–65.